Bioproducts in body fluids for early brain disease detection
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study is looking for proteins in blood and other body fluids that could help detect brain diseases like Parkinson's, Alzheimer's, and ALS early. It aims to improve diagnosis and future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have one of these conditions: Parkinson's disease, Alzheimer's disease, Frontotemporal dementia (FTD), or ALS.
- If you have Parkinson's, you need at least two of the main symptoms (tremor, stiffness, slowness, or one-sided start) and have had improvement with Parkinson's medication.
- If you have Alzheimer's, your diagnosis must be supported by a positive test for amyloid (a protein found in the brain).
- You cannot have another major brain disease (like multiple sclerosis, epilepsy, or previous dementia).
- You cannot have a pre-existing psychiatric condition.
- You must be able to sign an informed consent form (if you have Alzheimer's, FTD, or ALS).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
This study tests whether a saliva sample can help tell the difference between brain diseases like Alzheimer's, Parkinson's, and related conditions. By using a special laser technique, researchers hope to find a quick, non-invasive way to make an earlier and more accurate diagnosis.
This study is looking for people with neurodegenerative diseases (like Alzheimer's, Parkinson's, ALS) to help researchers find new markers in the body that could help understand these conditions better and possibly lead to better treatments.
This research study tracks how brain damage progresses in rare neurodegenerative diseases like frontotemporal dementia, primary progressive aphasia, PSP, CBS, and ALS. Researchers use brain imaging and tests to understand how these diseases spread in the brain, which could help develop better treatments.
This study looks for “autoimmune-like” (immune-system) features in brain-related diseases such as Parkinson’s and Alzheimer’s, using genetic testing and other assessments. Results may help researchers understand what drives these conditions and who might be more likely to have immune-related changes.
This trial is collecting saliva samples from people with Alzheimer's, Parkinson's, or other brain diseases to find new ways to diagnose them. It may help improve early detection.
Hear when a new Frontotemporal Dementia (FTD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.